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1 Abstract 22 
The majority of current state of the art microfluidic devices are fabricated via replica molding of the fluidic 23 
channels into PDMS elastomer and then permanently bonding it to Pyrex surface using plasma oxidation. 24 
This method presents a number of problems associated with the bond strengths, versatility, applicability to 25 
alternative substrates and practicality. Thus, the aim of this study was to investigate a more practical 26 
method of integrating microfluidics which is superior in terms of bond strengths, reversible and applicable 27 
to a larger variety of substrates, including microfabricated devices. 28 
To achieve the above aims, a modular microfluidic system, capable of reversible microfluidic device 29 
integration, simultaneous surface patterning and multichannel fluidic perfusion, was built.  30 
To demonstrate the system’s potential, the ability to control the distribution of A549 cells inside a 31 
microfluidic channel was tested.  Then, the system was integrated with a chemically patterned 32 
microelectrode array, and used it to culture primary, rat embryo spinal cord neurons in a dynamic fluidic 33 
environment. 34 
The results of this study showed that this system has the potential to be a cost effective and importantly, a 35 
practical means of integrating microfluidics. The system’s robustness and the ability to withstand extensive 36 
manual handling has the additional benefit of reducing the workload. It also has the potential to be easily 37 
integrated with alternative substrates such as stainless steel or gold without extensive chemical 38 
modifications. The results of this study are of significant relevance to research involving neurobiological 39 
applications, where primary cell cultures on microelectrode arrays require this type of flexible integrated 40 
solution. 41 
 42 





1 Introduction 44 
Microelectromechanical systems (MEMS) are small devices aimed towards miniaturization of experiments 45 
and methods of collecting data. The current state of the art MEMS devices can be very complex, highly 46 
engineered and often integrate surface chemistry modifications and  microfluidics with other micro-47 
fabricated components [e.g. 1, 2, 3]. 48 
Microfluidics is a technology and field of research where relatively small volumes of fluids are pumped 49 
through channels of micrometer scale [4]. Flow of fluids of such low volumes is dominated by surface 50 
tension, viscosity, surface area to volume ratio and diffusion.  51 
The combination of these factors results in laminar flow, where separate streams of fluid can flow side by 52 
side with out turbulent mixing [5]. 53 
The interest in microfluidics stemmed from the demand for miniature devices, capable of performing 54 
chemical analysis. Even though systems such as gas chromatography (GC) and high pressure liquid 55 
chromatography (HPLC) provided high sensitivity and resolution of chemical composition, these systems 56 
were limited for laboratory use only. Hence, in the attempt to perform similar analysis on a micro-scale, 57 
outside of the laboratory, the research and development of microfluidic technology begun [6].  58 
Microfluidic (µF) devices are essentially microscopic networks of fluidic channels. These channels can be 59 
etched into glass [7], silicon [8] moulded into a block of structural polymer such as  cyclic-olefin 60 
copolymer (Zeonor) [9], poly-methyl methacrylate (PMMA) [10] or photo curable perfluoropolyether 61 
(PFPE) [11, 12]. Additional materials suitable for fabrication of µF devices are described in the review 62 
article by Nge et, al. [13]. The design and dimensions of these devices as well as choice of base material is 63 
governed by the experimental requirements and cost. For example, experiments involving biological cell 64 
cultures require that the μF device and the substrate are optically transparent and compatible with light and 65 
fluorescent microscopy. Materials such as polydimethyl(siloxane) (PDMS) and Pyrex fit these criteria. 66 
PDMS is by far the most common material used for fabrication of μF devices. The common listed attributes 67 
of PDMS are its low cost, high transparency, good surface conformity, gas permeability, solvent resistance 68 
and bio-compatibility [14, 15]. Using PDMS, a new μF device can be made within 90 minutes, provided 69 
that the masters are available. 70 
In order for the μF device to function as intended, the micro-channel network must be sealed by bonding it 71 
to another surface. For example, 3D devices can be made by aligning and bonding one μF device to a 72 
second device with a complementary network [16, 17]. The most common approach however, is to 73 
permanently bond the μF device to a Pyrex slide or coverslip. This bond is achieved by plasma oxidation of 74 
both surfaces followed by alignment and conformal contact [18]. The permanency of the bond between the 75 
PDMS μF device and its substrate is generally desired, seemingly providing a watertight seal; however, it 76 
becomes a limiting factor when used with expensive, complex substrates such as microelectrode arrays 77 
(MEAs) [19]. MEAs are micro-fabricated devices used for collecting electrophysiological data from 78 
neurons or cardiomyocytes [20]. Due to their sensitivity to changes in surface chemistry (apart from the 79 
standard coating with cytophilic compounds e.g. PLL or fibronectin) the scope of application is narrow.  80 





single, specific application. The limitation of the permanent bond becomes more apparent if the μF fails 82 
and detaches from the surface. This leaves the MEA permanently contaminated with portions of PDMS. 83 
The contaminating PDMS can be dissolved using, for example, a solution of tetra butyl ammonium fluoride 84 
(TBAF-75% wt. in water) [21]. However, this can result in coating the entire MEA with PDMS as it re-85 
adsorbs to the surface from the TBAF solution [22-24]. Since PDMS is also an electrical insulator, the 86 
adsorption of PDMS can increase the microelectrode impedance, making them insensitive to cellular 87 
electrical [24, 25].  88 
The second limitation of permanent µF integration is related to patterned surface chemistry modifications 89 
and cell culture [26, 27]. In addition to chemical bonding, plasma treatment is primarily used to remove 90 
organic surface contaminants; hence, patterning of  cell adhesion proteins (e.g. laminin, fibronectin or 91 
streptavidin) prior to plasma treatment, will be ineffective as the protein will be etched from the surface 92 
[28]. Additionally, the plasma treated surfaces, such as polystyrene or silicon nitride passivation, become 93 
cytophilic, preventing the biological cells from distinguishing between the protein pattern and the non-94 
patterned, “background” surface [29]. 95 
Lastly, to date there has been a large number of devices built through integration of MEA with either 96 
microfluidics or patterned surface chemistry [30-32]. However, there are limited numbers of studies 97 
attempting to integrate all three components into a single device [33]. 98 
Hence, the aim of this study was to design and build a modular system which allows simultaneous, 99 
integration of microfluidic devices with chemically patterned MEAs and neuronal cell culture. To achieve 100 
this level of integration, the µF devices were attached in reversible manner, relying on mechanical force, 101 
rather than chemical bonds to create a functional fluidic network. Substituting the PDMS bonding method 102 
allowed the patterning of the MEA surface chemistry. Furthermore, the reversible nature of the µF device 103 
integration makes it easy to add or remove the microfluidic element at the desired stage of an experiment. 104 
Such a system has the potential to expand the scope of MEA application, making these devices suitable for 105 
simultaneous experiments with surface chemistry, microfluidics, tissue culture and 106 
electrophysiology.   In addition, our goal was to ensure that this system was practical in terms of its size 107 
and complexity, and that it could withstand regular use and manual handling.   108 
 To demonstrate the feasibility of our strategy, we used this system for the culture of A549 cells in a 109 
differential microfluidic environment and for the multichannel perfusion of a patterned, primary neuronal 110 
culture on the surface of an MEA. 111 
2 Materials & Methods 112 
2.1 Materials 113 
Fibronectin, poly-D-lysine (PDL), fluorescein isothiocyanate tagged poly-L-lysine and Terg-a-zyme were 114 
purchased from Sigma-Aldrich, U.K. B-27 supplement, Dulbecco’s Modified Eagles Media (DMEM), 115 





purchased from Invitrogen, USA via Bio-Sciences, Ireland. Single sided adhesive, polymerase chain 117 
reaction film, AB 0558 was purchased from Thermo Scientific, Germany. PDMS (Sylguard 184) was 118 
purchased from Dow Corning, UK. Biocompatible double-sided pressure sensitive adhesive tape, Orabond 119 
1397PP was purchased from Orafol, Germany. Halogenated ether (Isoflow) used for rodent anesthesia was 120 
supplied by Dept. of Anatomy.De-ionised (DI) water was purified using an Elga Purelab Ultra (Ultra 121 
Genetic) water purification system (Veolia Water Systems, Ireland). The de-ionised water used throughout 122 
had resistivity of 18.2 MΩ·cm. The MEAs, the alignment set-up, poly(methyl methacrylate) and Nylon 123 
culture rings were all fabricated in house at Tyndall National Institute. The cell culture and the µF device 124 
perfusion was performed using a KD Scientific 410-CE syringe pump. The imaging was performed using 125 
inverted microscopes Olympus IX70 or Olympus IX50. Both microscopes were equipped with DP70 and 126 
DP12 digital cameras respectively. Eppendorf 5810 centrifuge was used to separate the cell 127 
suspension. 128 
2.2 The basic steps of µF system integration 129 
1) MEA fabrication 130 
2) Fabrication of the culture chamber, the µF device module and the reservoir module 131 
3) MEA integration with the culture chamber 132 
4) MEA Surface chemistry modification (coating or patterning)  133 
5) Cell culture 134 
6) Attachment of the µF device to the MEA 135 
7) Perfuse the culture for a predetermined amount of time. 136 
2.3 The design process 137 
Our aim was to use the MEA as the foundation to build a system which would simultaneously allow the 138 
culturing of primary neurons, study the effects of surface chemistry patterning (patterned cell adhesion)and 139 
microfluidic perfusion, and record electrophysiological activity of the cultured cells. 140 
The MEA is simply an interface between the electrically active neuronal cells and a set of amplifiers; 141 
hence, it was paramount that the integration of the microfluidics did not interfere with data collection or the 142 
associated hardware  (hot-plate, amplifiers and the PC). The key consideration was the outer diameter of 143 
the cell culture ring as it has to fit through the designated opening of the amplifier (r=1.5 cm). Hence, it was 144 
insured that the dimensions of the set-up were kept with-in this limit. 145 
Initially, a number of methods of coupling the µF devices to the MEAs were investigated These tests 146 
included the conventional plasma bonding (32 W, 900mTorr for 1 min) and bonding using two bio-147 
compatible, UV-cure cyanoacrylates (Dymax 1-20791 and Norland NOA 68 cured for 20 min using the 148 
BioForce UV cleaner). However, these methods were insufficient for long-term use. The plasma bonded 149 
devices were very prone to leaks, while the cyanoacrylates, although initially showing a relatively strong 150 
bond, failed after two or three days when perfused with cell culture media. More importantly, all of the 151 





However, even if permanent bonding was a reliable method, it would have made it difficult to chemically 153 
pattern the surface either prior or after the µF integration. Hence, our solution was to devise a method of 154 
reversibly coupling the µF device to the MEA (see sections: 2.4.3, 2.4.4 and 2.4.5). 155 
The patterning of the MEA for the purposes of clustering cell adhesion on and around the microelectrodes 156 
presented different constraints. As the MEA is an electrical interface, the quality of the signal delivered to 157 
the amplifier is greatly influenced by the electrode surface chemistry. Permanent modifications, such as 158 
accidental PDMS adsorption which occurs during a process of micro-contact printing (µCP) for example, 159 
increases the electrode impedance and noise (see supplementary section S.5). Hence, to limit the exposure 160 
of the electrodes to the PDMS, the surface patterning was performed using the specifically designed, µF 161 
device. The fluidic channel network of this device corresponded to the layout of the microelectrodes on the 162 
MEA. This method ensured that the microelectrodes did not come into direct contact with PDMS during 163 
PDL-fibronectin perfusion.  164 
2.4 Fabrication steps 165 
2.4.1 Silicon masters 166 
The µF devices used for this study were fabricated by replica molding of PDMS against a silicon master. 167 
Two sets of etched silicon masters were fabricated in-house using the Bosch process [34]. The detailed 168 
fabrication protocol is outlined in the supplementary section S.1. 169 
One set of masters was intended for surface patterning (Fig. 1(a)), the second set was used to fabricate the 170 
µF devices for cell culture perfusion (Fig. 1(b)). Initially, the surface patterning was intended to be carried 171 
out via micro-contact printing (µCP) rather than µF patterning. However, after a comparison between the 172 
two methods, µF patterning proved to be more consistent producing uniform pattern features; hence, it was 173 
chosen as the preferred method (see supplementary section S.4)  174 
The dimensions of the masters were as follows: the master for patterning was 4.8 mm in diameter and 175 
featured a grid of circular chambers (r=30 µm, h=15 µm, 200 µm apart) interconnected with short channels 176 
(w=20 µm, h=15 µm). This layout directly corresponded to the microelectrodes on the MEA. The master 177 
for perfusion µF had a diameter of 1.7 cm, with a 2000 (W) x 5000(L) x 100 (H) µm central channel and 178 
two perpendicular 600 µm wide inlets. To ensure that the described design was suitable for generating 179 
laminar flow and microfluidic gradients, a COMSOL computational fluid dynamics (CFD) simulation was 180 
performed. 181 
Following the CFD simulation,  the masters were fabricated and prepared for PDMS replica molding. The 182 
masters were silanized with Tridecafluoro-1,1,2,2-tetrahydrooctyl-1-trichlorosilane (TFOCS) as previously 183 
described [35-37]. This layer served as an effective release agent for PDMS. Briefly, the silanization with 184 
TFOCS was performed inside a desiccator at RT. First, lint-free tissue was placed inside the desiccator and 185 
soaked with 2-3 drops of TFOCS. Then, the silicon masters were then placed in the desiccator and air was 186 
evacuated for 1 min.  The reduced pressure induced the evaporation of TFOCS. The vacuum was then 187 
turned off and the masters were left in the sealed desiccator for 30 min. The TFOCS formed a monolayer 188 





a)      b) 190 
  191 
Fig. 1: The schematics of the µF device designs used for a) surface patterning and b) cell culture 192 
perfusion. In (a), the circular areas indicated with red arrows were r=30 µm and 200 µm apart. The 193 
channels between the circular areas were 20 µm wide. This layout aligns with commonly used 8x8 194 
MEAs. In (b), the green and the red circles indicate the locations for the three fluid inlets and the 195 
waste outlet respectively. The large channel was 2000 µm wide, the narrower, side inlets were 600 196 
µm wide. 197 
  198 





2.4.2 Microelectrode array fabrication 199 
Our initial integration tests were carried out on the commercial, silicon nitride (SiN) passivated MEAs 200 
(60MEA200/30iR-Ti and 60MEA200/30iR-ITO; Multi-Channel Systems GmbH, Reutlingen, Germany). 201 
However, due to the relative high cost, irreversible modification or fouling, the experimentation was 202 
switched to the in-house devices fabricated using the bi-layer lift off method [38]. The arrays consisted of 203 
59 microelectrodes of  30 µm, arranged in an 8x8 grid. The conductive tracks of the MEA and the surface 204 
surrounding the microelectrodes were passivated with 500 nm layer of aluminium nitride (AlN) or SiN. The 205 
microelectrode layout and dimensions were similar to the commercial devices. Using these dimensions 206 
ensured that our MEAs could also be integrated with the Multi-Channel Systems MEA1060 amplifiers for 207 
recording electrophysiological data (for the MEA fabrication protocol, see supplementary section S.2). 208 
2.4.3 Culture chamber modules 209 
Culturing cells on the MEAs requires these devices to be integrated with culture chambers. These chambers 210 
were fabricated from poly(methyl methacrylate) (PMMA) or Nylon using a computer numerical control 211 
(CNC) machine. The chambers were 5 mm tall with inner diameter 1.7 cm and outer diameter of 2.6 cm. 212 
Each custom chamber featured four equally spaced, threaded openings. These openings allowed other parts 213 
to be securely attached to the culture rings via M5 threaded screws. Once fabricated, the chambers were 214 
washed with household detergent, aligned and attached to the MEA using the Orabond 1397PP double 215 
sided tape. 216 
 217 
2.4.4 Reservoir plate module for µF device 218 
Traditional multichannel (3 or more) perfusion of µF devices requires the use of two or more pumps with a 219 
fluid reservoir for each channel. This increases the physical experimental set-up, quickly becoming 220 
unpractical and unreliable. To try and keep the size of the system to a minimum, it was attempted to perfuse 221 
the µF device using passive methods such as gravity and surface tension driven perfusion (see the 222 
supplementary section S.3). Unfortunately, the passive methods, although advantageous due to their small 223 
size, proved too unreliable and prone to spontaneous flow termination. Thus, to keep the size of the 224 
experimental set-up to a minimum while connected to the external syringe pump, the media reservoirs were 225 
integrated into the MEA assembly. This was achieved through fabrication of the “reservoir plate”. This 226 
component housed the three fluidic reservoirs and was used to physically press the µF device against the 227 
MEA surface., The reservoir module was designed to anchor to the culture chamber module using screws. 228 
The positioning of the reservoirs matched that of the µF device channel inlets.  Importantly, as well as 229 
housing the media reservoirs, this module was also tasked with mechanically pressing the µF device against 230 
the MEA surface during the experiments (see section 2.4.5). The fabrication of the reservoir module is 231 
summarized in Fig. 2.  232 
 233 





a)      b) 235 
 236 
Fig. 2: a) The schematic of reservoir plate fabrication. 1) 5mm x 26 mm2 PMMA block. 2) Drilling of 237 
the pilot openings. 3) Drilling of the reservoirs using the 7mm drill bit. 4) Drilling of the pressure 238 
release opening using 1.5 mm drill bit. 5) Attachment of the single sided adhesive PCR film (AB 0558) 239 
to the underside of the plate (red). This PCR film served as the gasket to ensure a watertight seal 240 
between the reservoir plate and the culture chamber. b) The image of fabricated reservoir plate 241 
complete with the opening for the M5 threaded bolts. 242 















2.4.5 Fabrication of perfusion µF device modules 244 
To achieve robust, reversible integration of the µF device with the MEA, this module was designed to fit 245 
tightly within the culture chambers (see section 2.4.3). These modules were fabricated using PDMS. The 246 
pre-polymer was mixed with the hardener at the ratio of 10:1, degassed and cured at 100 °C for 1 h. The 247 
fabrication of the µF modules for cell culture perfusion and its integration with an MEA is described in Fig. 248 
3. To address specific practical issues, the µF device was fabricated in two molding steps. The first step 249 
ensured the good alignment of the microfluidic channels relative to the mold and the efficient degassing of 250 
PDMS in close proximity to the fluidic channels. The second molding step was used to fabricate a flat 251 
surface suitable for forming a functional watertight seal with the reservoir plate (see section 2.4.4).  252 
  253 










Fig. 3: a) The schematic of µF device fabrication: 1) the silicon master (black) is sandwiched between 260 
the Pyrex slide (blue) and a culture chamber (gray). 2) The assembly is clamped (red chevrons), the 261 
well is partially filled with pre-polymer PDMS (yellow), degassed and cured. 3) The clamps are 262 
removed and fresh pre-polymer PDMS (yellow) is poured onto the cured PDMS (green). 4) A second 263 
Pyrex slide is attached. 5) The slide is clamped and PDMS cured again. 6) After cure, the parts are 264 
disassembled to produce the µF device. b) The PDMS µF device fabricated using the steps in (a). c) 265 
The assembly sequence. The culture chamber is aligned and attached to the MEA. The µF device is 266 
inserted into the culture chamber. The reservoir plate is attached to the culture chamber with M5 267 



















2.5 Surface patterning 270 
2.5.1 Alignment 271 
To demonstrate that the modular µF system (Fig. 3) was compatible with patterning of surface chemistry, 272 
the MEAs were patterned with PDL and Fibronectin. The patterning was achieved by aligning a small µF 273 
device (Fig. 1(a)) with the microelectrodes and perfusing the channels with the polymer-protein solution. 274 
The alignment set up consisted of a rectangular base and lid with an opening in the centre. The alignment 275 
steps are shown in Fig. 4(a). The “vertical” and the “horizontal” 20 µm wide channels of the µF device 276 
(fixed to the platform on the aligner) were used as the alignment marks for the 30 µm electrodes on the 277 
MEA surface. The correct alignment placed the microelectrodes in the centres of the 60 µm circular 278 
chambers of the µF device (see supplementary section S.4). 279 
2.5.2 Patterning 280 
Once the patterned µF device was temporarily attached, it was filled with PDL-Fibronectin mix (1:1 281 
mixture of 100 µg mL-1 PDL and 25 µg mL-1 Fibronectin in PBS) via PDMS vacuum treatment as 282 
previously described [39]. Briefly: the substrate with the attached µF device was placed into a vacuum (~ 283 
100 mTorr) for 5 min. After vacuum exposure, two small drops of PDL-Fibronectin solution were placed 284 
onto the inlets of the µF device effectively blocking the access of air into the channels. As the pressure in 285 
the channels decreased, the drops of liquid were forced into the channels via ambient air pressure. The 286 
filled µF device was then incubated at 37 °C for 20 min. Following the incubation, the µF channels were 287 
rinsed by drawing a drop of DI water from one inlet into the channels using a lint free tissue. The µF device 288 















Fig. 4: a) The schematic of the basic steps involved in the alignment of the patterning microfluidic 300 
device (marked “µF”) with the MEA. (1) With the aid of an upright microscope, the MEA is aligned 301 
with the µF device below it. (2) The nuts were tightened to bring the aligned MEA surface into 302 
contact with the µF device. Once the µF device is attached to the MEA, it can be lifted from the rig. b) 303 
The schematic representing the basic steps of MEA patterning via vacuum treatment of the µF device. 304 
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2.6 A549 cell culture 306 
The A549 cells were used to demonstrate the concept of controlling the cell distribution within a 307 
microfluidic channel. These cells were selected due to their robustness and the high rate of division. The 308 
A549 cell line produces a confluent layer in 24 to 36 hours and is well suited for testing differential 309 
microfluidic environments.  310 
 The cells were cultured and split as per standard protocol. The A549 cells were seeded at a density of 311 
~3.5x105 cells mL-1 in 700 µL of DMEM   and were allowed to adhere to the substrate for 1h. Following 312 
the cell attachment, 500 µL of the cell culture media was removed and the µF device, which has been pre-313 
soaked in HBSS for 48 h at 37 °C, was inserted into the well and secured via the reservoir plate. The pre-314 
soaking in HBSS was used to saturate PDMS and reduce the chances of air bubble formation during 315 
perfusion. The µF device was perfused at rate of 10 µL h-1 with DMEM supplemented with 10% FBS from 316 
two separate reservoirs. The third reservoir was filled with DMEM without growth factor supplements. The 317 
A549 culture inside the T-75 flask was used as the control. The cell culture was imaged before and after µF 318 
perfusion using an inverted microscope  319 
2.7 Primary neuronal culture 320 
The neural cells were harvested from the spinal cords of Sprague Dawley rat embryos on the 14th day of 321 
gestation (E14). The neuronal tissue was acquired as described elsewhere [40]. Briefly, a pregnant 322 
Sprague Dawley rat was anesthetized by inhalation of halogenated ether vapor in a bell jar. Tail pinch 323 
and eye rub tests were performed to ensure that the rat was unresponsive and did not feel pain. The 324 
rat was then killed by decapitation and the embryos were extracted via a cesarean section. The 325 
embryo neuronal tissue was dissected under a microscope and suspended in sterile HBSS prior to 326 
dissociation. In cases when the tissue had to remain un-dissociated for more than 30 min, it was 327 
suspended in cool Neurobasal media instead of HBSS. To dissociate the nervous tissue, it was 328 
incubated in 5 mL of trypsin at 37 °C for 5 min.  To stop the action of trypsin, 500 µL of trypsin 329 
inhibitor or 500 µL of FBS was added to the tissue suspension. The tissue was dissociated by 330 
trituration using a P1000 Gilson pipette then the cell suspension was spun in a centrifuge for 5 min at 331 
1100 rpm to separate the neuronal cells from the trypsin solution. After the spin, the supernatant 332 
was discarded and replaced with 1 mL of Neurobasal media. The pellet was gently triturated again 333 
for few minutes to re-suspend the cells in fresh media. The neurons were seeded onto the surface of 334 
the MEA at the density of 1x105 cells cm-2 in 700 µL of Neurobasal media supplemented with 2% B27, 335 
10% FBS and 10 µl ml-1 GlutaMAX. After 2 days in vitro (DIV) on the MEA surface, the HBSS saturated 336 
µF device was attached as described above and the neurons were perfused for 24 h at a volumetric rate of 337 
5µL h-1. 338 





3 Results 340 
3.1  Gradient controled cell distribution 341 
Microfluidic gradients offer the potential to control cell population distribution based on their nutrient 342 
requirements.. Importantly, in vivo, the development of the structures of the central nervous system (CNS) 343 
is greatly influenced by the trophic factor gradients in the extracellular space, resulting in areas more suited 344 
to specific types of neuronal cells. This phenomenon is  particularly important for electrophysiological 345 
experiments because the neuronal electrical activity is known to be influenced by the presence of other 346 
neuronal cell types [41, 42].  347 
Prior to fabrication of the silicon masters and the µF devices, a COMSOL simulation of the channel 348 
perfusion was performed. The simulation was intended to provide a representation of the gradient 349 
formation during the perfusion of the µF device. The shape of the microfluidic gradient generated using the 350 
COMSOL simulations corresponded well with the gradient generated experimentally, inside the 2000 µm 351 
channel (Fig. 5 (a) and (b)). 352 
Following the test of the gradient formation, the µF device module was used to control the distribution of 353 
A549 cells inside the channel. This test was intended to demonstrate that the reversibly attached µF device 354 
can be used effectively for generating a differential, cell culture environment. This capability of µF devices 355 
has been previously demonstrated using trypsin or SDS fluidic gradients [43-45]. However, rather than 356 
using potent detergents, it was demonstrated that the distribution of A549 cells can also be controlled via 357 
exclusion of growth factors (FBS and GlutaMAX) from a perfusing gradient. After 24 h, the population of 358 
A549 cells that were perfused with un-supplemented media was visibly reduced while the cells perfused 359 
with normally supplemented media did not show any obvious reduction in the population confluency (Fig. 360 






a)      b) 363 
 364 
c)      d) 365 
   366 
e) 367 
 368 
Fig. 5: a) COMSOL simulation of the µF device perfusion showing the formation of separate streams 369 
and laminar flow inside the fluidic channel and in close proximity to the side inlet (volumetric rate: 370 
20 µL min-1). b) The fluidic gradient generated using the µF device. The device dimensions were 371 
identical to those used in COMSOL simulation. The perfusion rate was set to 8 µL min-1. c) A549s on 372 
the supplemented side after 24 h perfusion. d) A549 on the un-supplemented side after 24 h 373 










3.2 Patterned neuronal growth 375 
Patterning of neuronal cells in vitro using surface chemistry modifications is a well-established 376 
methodology [26, 27, 30, 46]. The guidance of neuronal growth using the surface chemistry and trophic 377 
factor gradients during the development of the CNS in vivo, is also well documented [47, 48]. In fact, the 378 
combination of the surface chemistry with the trophic factor gradients in the extracellular space plays one 379 
of the most important roles in the correct formation of the CNS architecture [49]. To demonstrate the 380 
neuronal patterning generated via surface patterning, the µF device (See Fig. 1(b)) was attached to the SiN 381 
coated Pyrex substrate by conformal contact. The microchannels were filled with the 100 µg mL-1 solution 382 
of PLL-FITC and incubated with the surface for a period of 20 min. After incubation, the µF device was 383 
removed and the substrate was imaged using a fluorescent microscope.  Fig. 6 (a) shows the PLL-FITC 384 
pattern on SiN surface generated using µF patterning method. Seeding the primary neuronal cultures onto 385 
the PLL (a cell adhesion promoter) patterned substrate resulted in patterning of neuronal cells. The results 386 
are consistent with previous reports that used adsorbed polylysine on bare SiN surface [50, 51]. The 387 
neurons remained pattern compliant up to 13 DIV (Fig 6. (b) and (c)). The long term viability and 388 
compliance of neurons to the patterned surfaces is an important and promising result because after 12-14 389 
DIV, the neurons form an extensive, electrically active network capable of spontaneous, synchronized 390 
electrical activity (See supplementary section S.5).  391 
 392 





a)     b) 394 
  395 
c) 396 
 397 
Fig. 6: The fluorescence images of surface patterns generated using the µF device perfused with a) 398 
fluorescein solution and b) patterned, E14 rat embryo spinal cord neurons on SiN coated Pyrex 399 
substrate at 2DIV (Substrate patterned with 100 µg mL-1 PLL). c) Patterned growth of E14 rat 400 
embryo spinal cord neurons at 13 DIV. The neuronal growth is compliant with the PLL-FITC 401 
patterned surface (green lines). 402 





3.3 Reversible integration of µF device with patterned neurons on MEA 404 
surface 405 
Following the separate experiments with the control of cell patterning and distribution on the Pyrex 406 
substrates, the surface of an MEA was patterned with PLL-fibronectin solution and used for culturing of 407 
patterned neurons inside the perfused, reversibly integrated microfluidic channel. The reversibility of the 408 
µF device attachment is of paramount importance because it allows the chemical patterning of the MEA 409 
surface. 410 
Fig. 7(a) shows the neuronal culture prior to the attachment of the µF module. At this stage of the cell 411 
culture, the neuronal patterning is shown by the preferential attachment of cells to the PDL-Fibronectin 412 
pattern (green pattern).  After 2DIV, the µF module was successfully integrated with the existing patterned 413 
culture and mechanically secured using the overlying PMMA culture chamber plate. The culture was then 414 
perfused for the 24 h period at a rate of 5 µL h-1 (Fig 7 (b)). The integration of the µF device did not have 415 
any obvious negative effects regarding the neuronal viability and pattern compliance. Interestingly, the µF 416 
device perfusion has resulted in a marked reduction in the number of dead, floating neurons (white arrows 417 
in Fig. 7(a)). 418 
This result represents the first demonstration of an MEA simultaneously and reversibly integrated with a 419 
functional µF device and chemically patterned neuronal network. The reversible integration of the µF 420 
device, allows this assembly to sustain the culture in potentially more favorable static environment without 421 
sacrificing the ability to perform µF experiments. The aligned, reversible attachment of patterning and 422 
perfusing µF devices ensures that the microelectrodes are positioned inside the fluidic channels, avoiding 423 
the direct contact and contamination with PDMS. An additional benefit of the reversible attachment is the 424 
ability to remove the µF device, and carry out the remainder of the cell culture experiment under “normal”, 425 
static conditions.    426 
Importantly, this result also represents an in vitro system capable of controlling the formation of neuronal 427 
networks using the similar strategies to those found in vivo (surface chemistry and diffuse trophic factor 428 
gradients). The combination of these factors, allows a high degree of control over the in vitro neuronal 429 
cultures in terms of cell placement and types; thus, making it possible to build defined neuronal circuits 430 
consisting of required cell types. Further, the electrical activity of these neuronal circuits can be monitored 431 
or stimulated using the integrated MEA.  432 
The combination of the above capabilities has produced a powerful, flexible, multifunctional research tool 433 
for experiments involving electrophysiology, neuronal guidance, neuromodulation, regenerative 434 
neuroscience or drug screening. 435 









Fig. 7: a) Patterned neuronal network on the MEA surface. The green pattern indicates surface 441 
modifies with PDL-Fibronectin. The red arrows indicate the dead neurons, floating in the culture 442 
media. b) Neurons seen in (a) but with an integrated µF device. Note: images (a) and (b) show the 443 
same neuronal pattern. The yellow stars indicate the same electrodes. The red dashed lines indicate 444 
the µF channel wall where the side inlet (600 µm wide) meets the large (2000 µm wide), main 445 













4 Discussion 447 
The aim of this study was to design and build a microfabricated system, capable of simultaneously 448 
controlling the distribution of neuronal cells using the combination of surface chemistry with the 449 
microfluidic gradients and monitor the neuronal electrophysiological activity. An additional aim was to 450 
address some of the practical issues associated with the integration of PDMS microfluidics with MEAs. 451 
Specifically, in our experience; the inconsistent bond of the µF devices with the substrate, the device re-452 
usability and the resultant poor range of application, make it difficult to justify permanent µF integration 453 
with expensive, seemingly re-usable MEAs. Even though, it has been shown that PDMS can be strongly 454 
bonded to SiN [52], this step narrows the range of application to experiments that do not require chemical 455 
surface patterning or multiple cell culture experiments. To date, only a small number of studies have 456 
attempted to address the issues associated with permanent PDMS bonding [31, 53]. Hence, this study 457 
described an alternative method of secure, reversible integration of the µF device with the MEA. This was 458 
achieved by fabricating a number of modules designed to physically press the PDMS µF device against the 459 
selected substrate. The permanently attached culture chamber module served to confine the µF device in the 460 
XY plane. However, if an alternative or new experimental design does not require the integrated 461 
microfluidics, this module can also be used as the conventional culture well, reverting the MEA to the 462 
original specification; and thus, maintaining a wider scope of application. 463 
The reservoir plate module served to press the µF device down against the surface. In addition, this module 464 
housed the media reservoirs which also resulted in reduced size of the setup. To avoid subjecting the 465 
chamber-MEA bond to excessive hydraulic pressure during perfusion, the system utilized suction to draw 466 
the media from the reservoirs through the µF channels making this system less prone to leaks. 467 
To demonstrate the functionality of this set up, we used the reversibly attached µF device to control the 468 
distribution of A549 cells on a Pyrex substrate. Following this, by culturing patterned neuronal population 469 
on the MEA integrated with the µF device, we demonstrated that this methodology allows for a more 470 
flexible experimental setup that is not subject to substrate µF device bond. 471 
This type of reversible integration has resulted in a multifunctional, integrated system, geared toward 472 
multiple neurobiological experiments. Specifically, our method allows the simultaneous integration of the 473 
MEA with chemical surface patterning, patterned neuronal cultures and multichannel microfluidic 474 
perfusion. Importantly, because the PDMS µF device does not have to mechanically support the perfusion 475 
lines, the assembled system proved to be user friendly and able to withstand extensive manual handling. 476 
The reversible µF integration with the MEA enables this system to 1) record or stimulate neuronal electrical 477 
activity as well as focally electroporate the cells on the surface [54]; 2) modify and pattern the surface 478 
chemistry to suit the experimental demands; 3) use the modified surface chemistry to control the neuronal 479 
network development 4) control the cell culture environment via microfluidic gradients; 5) test multiple µF 480 
device layouts during any stage of the cell culture and 6) monitor the microfluidic network in real time 481 
using conventional inverted microscopy techniques.  482 
The above capabilities enable this system to be used for different experiments involving any combination 483 





microfluidics and microscopy. The integrated system of this type has the potential to be applied to research 485 
in the fields of regenerative neuroscience or spinal cord injury for example. The ability to control the 486 
surface and fluidic environment of the neuronal culture is very useful because it is closely related to the in 487 
vivo models of neuronal growth and development [55]. The additional capability of this platform to record 488 
the neuronal electrical activity can be utilised to determine if the anatomical regeneration was accompanied 489 
by functional connectivity between the severed neurons. Alternatively, this platform can be applied to 490 
experiments involving neuromodulation. The added benefit is that the modulatory effects of various 491 
compounds can be focused on the selected parts of the neuronal culture using the microfluidic gradients. 492 
The effects of focal neuromodulation can then be measured by comparing the electrophysiological data. 493 
5 Conclusion 494 
This study has focused on designing and testing an alternative method of integrating the µF devices with 495 
MEAs to create a system with a broad scope of application. It was successfully demonstrated that the 496 
distribution of the A549 cells inside the channels of reversibly attached µF device can be controlled via 497 
fluidicgrowth factor supplement gradients. Furthermore, the compatibility of the reversible µF integration 498 
with MEAs and patterned neuronal networks in vitro wasdemonstrated. These results show that this 499 
methodology can potentially be used to construct a multifunctional, modular research tool geared towards 500 
experiments with electrophysiology, neuronal guidance and microfluidics. 501 
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7 Supplementary Section 669 
S.1 Fabrication of silicon masters 670 
 671 
The silicon masters for μCP stamps and the microfluidic devices were fabricated in-house fabrication 672 
facility. The very first step in this process was the drawing of the concept sketch using Google Sketch Up 673 
software. This stage outlined basic dimensions and features of masters to be manufactured. The sketch was 674 
then redrawn into a precise set of mask blueprints in AutoCAD by a qualified computer aided design 675 
(CAD) technician. The fabrication of masks was outsourced to Compugraphics, UK. Once the masks were 676 
fabricated, the silicon masters were fabricated by a qualified engineer via the following steps. A blank, new 677 
wafer was cleaned using the standard Radio Corporation of America (RCA) cleaning method. The RCA 678 
clean was designed to remove organic, inorganic and metal contaminants from the wafer surface without 679 
attacking the silicon itself (Kern, 1970). To define the master features, AZ 9260 resist was applied to the 680 
wafer and exposed through a photo-mask. The exposed photoresist was developed using HPRD 402 681 
developer. Using the Bosch process, the wafers were etched to the depth of 10 and 15 µm for the μCP 682 
stamps and 100μm for the μF devices. The Bosch process involves a sequence of etch and passivation steps 683 
(Laermer and Schilp, 2003). The etch steps were 5 sec long utilizing sulfur hexafluoride (SF6) plasma 684 
followed immediately by 2 sec. passivation with Octafluorocyclobutane (C4F8). The depth is controlled by 685 
the number of etch-passivation cycles performed. This method allows for creation of high aspect features in 686 
silicon crystal. After etch, the remaining photoresist was stripped by a combination of plasma and Piranha 687 
solution. All the steps above were performed by a trained silicon fabrication engineers. 688 





S.2 Fabrication of MEAs using the bi-layer method 690 
 691 
The MEA fabrication was carried out as follows: first, 4” Pyrex wafers (1 mm thick) were spin-coated with 692 
Hexamethyldisilazane (HMDS) primer at 4000 RPM for 50 sec to improve photoresist adhesion followed 693 
by spin-coating of Polymethylglutarimide (PMGI) resist. The wafer was then baked on a hotplate at 170 °C 694 
for 3 min. Following the resist bake, HDMS was spin-coated onto PMGI at 4000 RPM for 50 sec followed 695 
by spin-coating of Microposit S1813 imaging resist at 4000 RPM for 50 sec. The wafer was then baked on 696 
a hotplate at 115 °C for 2 min. 697 
The wafers were then exposed to metal level photo-mask (this mask defined the layout of the 698 
microelectrodes, conductive tracks and contact pads) in Karl Suss MA1006 mask aligner at 70mW cm-2, 699 
developed in Microposit 319 developer, rinsed in running DI water and oven baked at 90 °C for 30 min. 700 
Following the resist patterning, the wafers were treated with Ar plasma for 30 sec and 2x10-7 Torr in an 701 
evaporator to improve metal adhesion. Ti:Pt (10nm:100nm) was then evaporated onto the wafer at 80 °C. 702 
The metal lift off was performed at 80 °C in Microposit R1165 resist stripper. The metal patterned wafers 703 
were then rinsed in DI water before deposition of passivation coatings. 704 
Following the metal lift of, each device was coated with either: SiN, AlN or polyimide passivation. 500nm 705 
SiN passivation was deposited onto the devices by chemical vapour deposition (CVD) in STS310 PECVD 706 
system. AlN was deposited at the thickness of 650 nm by sputtering in Oxford Instruments Plasmalab 400 707 
Magnetron Sputtering system. Polyimide was spin-coated onto the devices at thickness of 6 µm and cured 708 
in a vacuum oven at 250 °C. 709 
The patterning of passivation coating was carried out as follows: The SiN and AlN passivation layers were 710 
patterned using the same procedure as described for metal deposition and patterning. However, the assisting 711 
layer of PMGI resist was omitted. An appropriate passivation level photo-mask was aligned with the metal 712 
features of the MEA. This photo-mask defined the areas that are free from passivation, i.e. the 713 
microelectrodes and contact pads.  Polyimide was patterned using 7 µm thick layer of AZ9260 photoresist 714 
instead of Microposit S1813 photoresist. 715 
After resist patterning, SiN passivation was etched in STS Inductively Coupled Plasma (ICP) using 716 
CF4/CHF3 chemistry. AlN passivation was etched via reactive ion etching (RIE) in Oxford Instruments RIE 717 
Plasmalab System100 using BCl3 chemistry. And finally, Polyimide was etched in ICP system using 718 
O2/SF6 chemistry. Following the passivation etch, the remaining resist was stripped using R1165 resist 719 
stripper and devices thoroughly rinsed in DI water. 720 















Fig. S1: The experimental comparison between the µF perfusion methods (hydrostatic pressure, 732 
liquid drop surface tension, syringe pump and peristaltic pump). a) Sequential images of gradients 733 
generated using the syringe pump. The volumetric rate was sequentially increased and the 734 
corresponding luminescence profiles (n=3) were measured. b) Sequence of images of fluidic 735 
gradients generated using gravity [e.g 56], surface tension [57, 58] and a peristaltic pump. The 736 
numbers 0.01-0.09 indicate the RPM setting of the peristaltic pump. The blue, dashed areas represent 737 
the pixels used for gathering the horizontal luminescence/fluorescence profiles. The red lines in the 738 
graphs indicate the gradient slopes. Scale bars: a) 650 µm, b) 1000 µm. 739 
Gravity Sur. 
Tension 






Fig. S2: Graph of gradient slopes measured from the fluorescence and luminescence intensity profiles 741 
of fluidic gradients. Solid slopes represent gradients generated with a syringe pump; thin dashed 742 
lines represent the gradients generated with a peristaltic pump. This data was used to determine the 743 
volumetric rates generated by the passive perfusions methods (Gravity and surface tension driven). 744 
Table T1: Perfusion method observations 745 
Perfusion Method Positive aspects Negative aspects 
Gravity Driven Perfusion Small, simple and cheap 
No external power supply 
Potential 24 h perfusion 
Potential for perfusion with multiple 
channels (more than 2) 
Low volumetric rate 
Large reservoir volumes 
Prone to spontaneous perfusion 
termination and bubble formation. 
Requires precise machining to control 
vol. rates. 
Difficult to load with perfusing 
solution 
Surface Tension Driven 
Perfusion  
Requires no extra equipment 
Reasonably low volumetric rate 
Gradients easily imaged using upright 
and inverted microscopes 
Prone to spontaneous perfusion 
termination and bubble formation 
V. poor control over initiation of 
perfusion 
Incapable of long term perfusion due 
to low reservoir volumes 
Difficult to load the device with 
perfusing solution, requires steady 
hands and good dexterity 
 
Syringe pump Very good control of volumetric rate 
Consistent 
Two channel perfusion 
Large reservoir volume 
Long term perfusion (2-3 Days) 
“Withdraw” function (model specific) 
The setup is bulky and time 
consuming 
Requires an external power supply 
Limited to number of channels 
(depending on the unit). 
Hard to integrate with tissue culture 
 
Peristaltic pump Good control of volumetric rate 
Bi-directional perfusion 
Less bulky than the syringe pump 
Two channel perfusion 
Large reservoir volumes 
The minimum volumetric rate is high 
as compared to syringe pump. 





Long term perfusion (2-3 Days) 
 746 
S.4 Surface patterning comparison between µF and µCP 747 
a) 748 
 749 
b)      c) 750 
  751 
d)      e) 752 
 753 
Fig. S3: Aligned µF patterning on MEA showing that the features of the µF device (e.g. the 60 µm 754 
circular chambers (red)) can be reliably aligned with the 30 µm microelectrodes (black) using the 755 
alignment setup and the upright microscope. Direct comparison of b) µF pattern with identical c) µCP 756 
pattern. d) Fluorescence profile comparison plot of (b) and (c). e) Integrated fluorescence data 757 








  760 
Fig. S4: Surface contamination with PDMS following the conformal contact during µCP. The 761 
deposition of the PDMS on microelectrodes has a negative effect on the electrode impedance and 762 
noise levels. 763 
 764 





S. 5 Electrophysiological recordings-testing the commercial MEA 766 
 767 
 768 
Fig. S5: a) Recorded signals from E14 rat embryo spinal cord at 14 DIV using the commercial, un-769 
patterned MEA (60MEA200/30iR-Ti). The initial seeding density was 5x105 cells cm-2. The recorded 770 
signals show good synchronization between channels 44, 55 and 61. The red vertical lines separate 771 
the timeframes that show electrical synchronization (blue indicator). b) Graph showing action 772 
potential fire-rate comparison. The simultaneous increase of fire rates in channel 44 (green) and 55 773 
(black) and to a lesser extent in 61 (red) indicates the synchronization electrical activity. Each 774 


























set to 40 kHz. Filtering (200 Hz high pass) and signal processing were performed off line using MC 776 
rack software. 777 
 778 
Fig. S6: The comparison of signal noise levels. The normal noise level (red trace) of +/- 10 µV is 779 
superimposed over the recording from a “noisy” electrode on the same array. The Ch. 12 baseline 780 
noise level was +/- 20 µV. 781 
 782 
